This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
SUPS 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Anastomotic stricture after minimally invasive radical prostatectomy: What should be expected from the Van Velthoven single-knot running suture? - Abstract
May 30, 2012
Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinations - Abstract
May 30, 2012
Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer - Abstract
May 30, 2012
Choline PET/CT in the diagnosis of primary and recurrent prostate cancer : Are there evidence-based indications? - Abstract
May 30, 2012
A novel curvilinear approach for prostate seed implantation - Abstract
May 30, 2012
Treatment outcomes in non-metastatic prostate cancer patients with ultra-high prostate-specific antigen - Abstract
May 30, 2012
Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerations - Abstract
May 30, 2012
Clinical characterization of prostate cancer potentially insignificant in the prostate biopsy - Abstract
May 30, 2012
AUA 2012 - European Randomized Study of Screening for Prostate Cancer (ERSPC): An update after 11 years of follow-up - Slide Presentation
May 30, 2012
AUA 2012 - Making sense of all the new options: Pragmatic considerations in CRPC - Slide Presentation
May 30, 2012
AUA 2012 - The absence of goal setting in the dialogue between metastatic prostate cancer (mCRPC) patients and their physicians: An opportunity for shared decision making? - Another Perspective
May 30, 2012
AUA 2012 - Does long-term aspirin use lower serum PSA levels? – Results from the Duke Prostate Center - Session Highlights
May 30, 2012
AUA 2012 - Unilateral prostate cancer: Analysis of predictors in search and Duke Prostate Center databases - Session Highlights
May 30, 2012
The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: Magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans
May 30, 2012
AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD
May 30, 2012
Management of patients with metastatic prostate cancer - Abstract
May 29, 2012
Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort - Abstract
May 29, 2012
Active surveillance for favorable-risk prostate cancer: Background, patient selection, triggers for intervention, and outcomes - Abstract
May 29, 2012
EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy - Abstract
May 29, 2012
Recent changes in the clinicopathologic features of Korean men with prostate cancer: A comparison with Western populations - Abstract
May 29, 2012
Page 1269 of 1417
Start
Prev
1264
1265
1266
1267
1268
1269
1270
1271
1272
1273
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free